Mile High Labs Files Type II Drug Master File with FDA for CBD Isolate
Mile High Labs continues to build its pharmaceutical-channel capabilities with a Type II DMF for CBD Isolate LOVELAND, Colo., Nov. 19, 2026 /PRNewswire/ -- Mile High Labs, a global leader in hemp-derived cannabinoid ingredients, today announced that it has filed a Type II Drug Master File...